Columbia Nephrology Associates, PA

Columbia, South Carolina 29203-6476

1 studies enrolling now · 12 studies all time

What they study most

ADPKD, Alport Syndrome, Autosomal Dominant Polycystic Kidney, Chronic Kidney Disease, Chronic Kidney Diseases, Chronic Renal Failure, Chronic Renal Failure Requiring Hemodialysis, Diabetic Nephropathies, Hyperphosphatemia, Iron Deficiency Anemia, Proteinuric Kidney Disease

Studies at this site

• Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease — Recruiting now
• Inaxaplin in Participants With Proteinuric APOL1 Mediated Kidney Disease With or Without Comorbidities — Running, not enrolling
• Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD) — Stopped early
• A Trial of Bardoxolone Methyl in Patients With ADPKD - FALCON — Stopped early
• A Trial of Bardoxolone Methyl in Patients With CKD at Risk of Rapid Progression (MERLIN) — Completed
• An Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE) — Stopped early
• Study to Evaluate the Efficacy of Tenapanor as Adjunctive Therapy to Phosphate Binder Therapy — Completed
• KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial) — Completed
• A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy — Completed
• A Phase 3 Study Comparing the Effects of Intravenous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin — Completed
• A Phase 3 Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin — Completed
• A Phase 3, Long-Term Safety Study of Intravenous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin — Completed